Clinical Trial Update: Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated bortezomib in patients with advanced cancer and kidney dysfunction. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Extranodal Nk T-cell Lymphoma Nasal Type
• Follicular Lymphoma
• Lymphomatoid Granulomatosis
• Mantle Cell Lymphoma
• Mucosa-associated Lymphoid Tissue Lymphoma
• Multiple Myeloma
• Nodal Marginal Zone B-cell Lymphoma

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma | Phase 1 | Status: COMPLETED